SureTrader SPDR Advertisement
Home > Boards > US Listed > Biotechs >

Verde Science Inc. (VRCI)

Add VRCI Price Alert      Hide Sticky   Hide Intro
Moderator: No Moderator mick, TomKG, resx18, dreubie
Search This Board:
Last Post: 9/3/2015 9:24:46 AM - Followers: 116 - Board type: Free - Posts Today: 0

                                FOLLOW $VRCI ON TWITTER ---------------->


                                                                  $VRCI Website ----->                           

Leading Cutting Edge Research for the Isolation of Highly effective Formulations for the Treatment of Chronic Medical Disorders

Verde Science (VRCI-OTC-PK) has established a high level Research and Development Team with expertise in Bioprocess Technology, Nanotechnology, Molecular Virology and Immunology, Pharmacology and Medical Device Design, which is focused on the isolation of new drugs and delivery systems for the treatment of a variety of medical issues, and the development of novel tests for the screening of emerging and contemporary medical issues.

Our initial primary area of investigation is Cannabis-based extracts to isolate and develop formulations for the effective treatment of specific medical conditions such as, migraines and pain management, loss of appetite due to chemotherapy treatment, multiple sclerosis, and seizures. Our scientists have identified certain cannabis extracts that they believe have significant promise for continued study.

Research will begin in India, where costs are much lower, and our team of scientists and alliance partners can respond much faster to new developments. Our expedited and low cost approach sets Verde Science apart from others in the biotech space.


Alliance Partners – Research & Development

Verde Science is establishing alliance partners to assist in its plans for the development and growth of the company.

Institute of Chemical Technology, Mumbai, India

Institute_of_Chemical_Technology_logoThe Institute of Chemical Technology (ICT), Mumbai, is India’s premier chemical engineering and technology research institute. The institute is dedicated to training and research in various branches of Chemical Engineering, Chemical Technology, and Pharmacy. Over the last 76 years it has acquired the status of being the premier and renowned institute of Chemical Technology in the country. Research has been an integral part of ICT since its inception and it has created over 500 first generation entrepreneurs. The ICT has brought considerable international recognition to India, and its stellar performance is reflected in the following: 1. The MHRD had evaluated all deemed universities in the country in 2009 rated ICT as Number One Deemed University with “A” grade. 2. The ICT has also been rated as Number One Institute by NPIU among 127 TEQIP funded Institutes, all over India, in October, 2010.

Sterkem Pharma Group of Companies

Sterkem-Group-Logo-Verde-Science-2The Sterkem Pharma Group of Companies was established in 1974 and has continued to market quality pharmaceuticals for over a third of a century. The family based enterprise has been a brand leader for Anti-arthritic drugs viz. Inmecin (Indomethacin) and its allied products. Injectable formulations, both powder and liquid were among the first products marketed by Sterkem. Today their marketing domain includes Anti-arthritic, Antidepressants, Analgesics, Antibiotics, and a range of Gynaecological and Obstetric drugs in different formulations. The most recent additions to their range of products are Multi-Vitamins, Anti-oxidants and Nutritional Supplements that strengthen the immune system.


Harp Sangha – Chairman / CEO
Mr. Sangha has been a founder, CEO and board member of several public companies and brings 27 years of entrepreneurial, operational and capital market experience to Verde Science. In 1986 he started his career as Investment Advisor and gained his affinity for raising capital for numerous startups and early stage public companies. Mr. Sangha departed this position in March 2006 to apply his unique ability of bringing capital to early stage projects and founded Douglas Lake Minerals. In the role of CEO, his leadership in Douglas Lake overcame rigorous operational challenges in the African environment and brought the value of the company to $240 million. He has also served as CEO, Secretary, and director of Sharprock Resources Inc. (OTCBB: SHRK) where he raised capital to explore a preproduction gold project in the Chukotka Region of Russia. He joined Rango Energy, Inc. in 2012 as Chairman of the Board and Chief Executive Officer. Mr. Sangha has established many valuable contacts and relationships with institutional clients worldwide.

David Alexander, CA, BComm – Chief Financial Officer
Mr. Alexander is a chartered accountant who graduated from the University of British Columbia with a BComm in Finance. He has managed the rapid growth of several early stage startup companies to major successes in their respective sectors. As CFO of the start-up Nortran Pharmaceuticals, Inc., a University of British Colombia based pharmaceutical research and development company engaged in the development and commercialization of cardiovascular therapies, he assisted in obtaining its initial financing and first discoveries. While at Nortran he worked closely with Dr. Walker and a group of scientists who had a vision to create solutions for life threatening arrhythmias of the heart, acute cough, and pain management. Nortran subsequently became Cardiome Pharma Corp., a successful Vancouver BC based pharmaceutical company listed on Nasdaq: CRME. While CFO of Arakis Energy Corporation, he managed its growth from startup to over a billion dollars in assets, and moved its public company listing from the Vancouver Stock Exchange to Nasdaq in New York. Arakis was an international oil and gas development company with wells in Kentucky, Oman, New Guinea and the Sudan. The company was subsequently sold to Talisman Energy Inc. and oil fields developed by Arakis have resulted in proven developed and undeveloped reserves of over 500 million barrels. The fields have been producing over 350,000 barrels per day for the last 15 years. During his tenure as CFO and controller at Columbia Trust Company, he managed the growth of its assets from $50 million to over $1 billion during a 5-year period. He implemented a comprehensive management system that enabled him to reduce administrative staff from 50 to 15, and managed a $20 million money market and stock portfolio. David left Columbia Trust when it was sold to a Toronto based trust company.

Craig Alford, MSc – Independent Director
Mr. Alford holds a Master of Degree of Science.  He has worked throughout North and South America, China, several Central Asian Republics, Russia, Australia and Africa. This experience has included independent consulting assignments, and positions within the management of major and junior company exploration companies. Mr. Alford has assisted the World Bank and the China-Africa Development Fund in tax policy and investment risk. He has been responsible for budgeting and the expenditure of hundreds of millions of dollars and has developed comprehensive economic analysis for billion dollar M & A transactions. Mr. Alford has worked as a consultant for Conoco Philips (COP:NYSE), China Railway (SHA:601390), and Teck Mining Ltd (NYSE:TCK). He has served as a director and Vice President in numerous junior companies and has played a key role in successfully raising over $40 million in equity.

John Percival – Independent Director
Mr. Percival is a successful Director and Managing Director of various companies in Australia. His career started as a stockbroker with a premier securities firm, Daysh Renouf & Co. in New Zealand, where he was trained in share market dealings, company listings and financings. After the 1969 Poseidon Nickel Boom in the Australian resource sector of the stock market, the company partners sent John to Australia to research and work in the mining sector. Upon his return to New Zealand in 1972, he took a position as Investment Manager with NZ United Corporation, a merchant bank, which later became Barclays Bank New Zealand Limited. At Barclays, he rose to the position of General Manager Investments, and he advised and managed over $500,000,000 of superannuation and private funds. When Barclays closed its New Zealand office in 1988, John returned to Australia where he worked in finance and securities for the State Bank of New South Wales. With over 50 years experience in the financial markets, he is considered an expert and specialist in investment strategies. He has successfully used his extensive contact base to support numerous companies’ in their capital raisings. John is also involved with a number of private asset management groups.

Bradley J. Dixon, J.D. – Independent Director
Mr. Dixon is an attorney and partner in the Boise, Idaho office of Stoel Rives, LLP, which has locations throughout the northwest and California. He is ranked by Chambers and Partners and was named in the 2013 Mountain States Directory of Super Lawyers. He has a wide range of litigation experience, which includes Agricultural, Natural Resources, Labor and Employment, and Product Liability cases. Mr. Dixon’s trial experience representing clients through complex litigation on a broad range of disputes including complex commercial litigation, employment, insurance coverage, products liability, title insurance, foreclosure and bankruptcy trial practice, as well his governmental affairs service experience meshes well with the future needs of Verde Science. With his broad legal background he can help guide Verde through the challenges of this business as it matures and spreads to more and more jurisdictions.

Manit Patel, BPharmSc., MBA – Chief Technology Officer
Mr. Patel earned a Bachelor in Pharmaceutical Sciences from The Institute of Chemical Technology in Mumbai, India, and an MBA from Queensland University of Technology in Brisbane, Australia. He was Director of Business Development for Sterkem Group, a Mumbai, India based pharmaceutical R&D, production, and marketing firm. At Sterkem he was responsible for business strategy and new product development, reporting directly to the Board of Directors. He successfully restructured the marketing and manufacturing operations to improve profitability. He was responsible for training a sales team of 150 sales representatives including 15 province managers. Subsequently, he was a market research manager at iData Research, an international market research consulting company dedicated to the provision of business intelligence for the medical device, dental and pharmaceutical industries. He managed global accounts for business development and consulting for cardiovascular devices and therapies. He built relationships with existing and new clients, and enhanced the growth potential of the company by working with the Analyst Team for new product development. Mr. Patel has a broad network of international business contacts throughout the pharmaceutical sector, which will be an important resource for Verde Science as it moves forward with its growth plans. He is a creative problem solver with focus on strategic planning to ensure continuous long-term success. He excels at business development by building relationships and engaging C-Level decision makers and his excellent interpersonal skills help him relate to culturally diverse audiences and managing staff in different countries across numerous time zones.

Dr. Shantesh Hede, Ph.D. – Director of Product Development
Dr. Hede heads Verde Science’s R&D programs and is based in Mumbai, India, where he directs the program on-site with Verde’s Research and Development partner, the Institute of Chemical Technology. He earned a Ph.D. in Bioengineering Systems from the MIT Portugal Program, a Master of Engineering Management from Duke University, and a Bachelor in Pharmaceutical Sciences from the Institute of Chemical Technology. Dr. Hede’s focus is to leverage the R&D platform alliances with existing partners in healthcare institutions, academia and the pharmaceutical industry for the identification and commercialization of specific formulations derived from the marijuana plant for the treatment of numerous medical conditions. His focus is to ensure Verde’s scientific activities develop applications that will produce significant intellectual property in areas of limited market competition to generate substantial value for company shareholders.

Louis Silver – Director of Investor Relations and Corporate Development 
Louis brings a record of success in both Fortune 500 companies and the entrepreneurial arena.  After completing graduate school Louis held several corporate finance positions at International Utilities, Inc., including Director of Cash Management and Banking Relations and Senior Financial Analyst.  He had several management roles while with Aramark, Inc., including Vice President of Administration, Senior Vice President of the Leisure Services Division, and President of the Public Vending Division.  Silver was founder of AAA Building Maintenance, Inc. a regional service company with 500 employees that was sold to Allegheny Beverage Corporation, and later founder and managing Director of Montgomery Capital Advisors, a boutique investment banking firm. Louis earned an MBA from Temple University, completed Ph.D. studies in marketing, and earned an M.A. in theology from the Palmer Theological Seminary of Eastern University.  He has served on numerous local philanthropic boards, including Montgomery County D.A.R.E., Big Brothers/Big Sisters, Baptist Children’s Service, ASSETS Montgomery County (regional microenterprise development program) Palmer Theological Seminary, and the Sheriff of Montgomery County Advisory Board.

Paul Pelosi, Jr. – Advisor
Paul Francis Pelosi, Jr. is a speaker on environmental policies that encourage individuals and local governments to take a more active role in conserving natural resources and reducing carbon footprints. Pelosi has spoken at conferences in Stockholm, Milan, and Amsterdam. Pelosi is a contributor to the anthology Inside the Minds: Navigating Green Construction and Energy Initiatives, forthcoming from Aspatore Books in Spring 2009.  Pelosi is a graduate of Georgetown University with a Bachelor of Arts in History (Cum Laude, 1991) and a JD/MBA (Joint Degree 1995) with an emphasis in International Business. In 1991, Pelosi was a Gillette All Star Athlete in Track and he received the Georgetown International Human Rights Award in 1994. Paul Pelosi has 16 years’ experience in advising emerging and Fortune 500 companies in the areas of finance, infrastructure, sustainability and public policy. Pelosi is a founding member of Cisco Connected Urban Development and under the direction of Cisco CEO John Chambers, Pelosi worked with San Francisco, Birmingham, Amsterdam, Hamburg, Lisbon, Madrid and Seoul to attempt to demonstrate how network connectivity might reduce carbon emissions in urban environments. In 2003, Pelosi was appointed by San Francisco Mayor Willie Brown to the city’s Commission on the Environment. The commission is responsible for developing policies and programs in recycling, toxics reduction, environmental justice, energy efficiency, commute alternatives, climate change, and the city’s urban forest. Pelosi served as President of the Commission. During his tenure, San Francisco implemented energy efficiency programs that resulted in a reduction of 28 megawatts of electricity, created programs that increased residential and commercial recycling from 46% to 70%, as well reduced San Francisco’s carbon emissions to 6% below 1990 levels, and became the first municipality to implement a ban on plastic bags.  Currently, Pelosi serves as Senior Vice President of Business Development at InfoUSA where he is responsible for identifying acquisitions and organizing programs to develop effective strategy for reducing waste and promoting greener practices in the market research industry. Pelosi also advises companies including NASA Ames Research Center and AirPatrol Corporation on a variety of infrastructure projects to promote both sustainable development and security. Prior to independent consulting, Pelosi served many years with Bank of America Securities, Bank of America Countrywide and JP Morgan – Chase Manhattan where he worked in Corporate Finance, Institutional Sales, and the Residential Mortgage Industry.  Pelosi has been a member of the California State Bar since 1996.

Sam Sangha – Global Corporate Development
Mr. Sangha began his career as an investment advisor at Global Securities Corporation in 2004 and focused on the natural resource and mining sector where he worked till 2010. Over that period Mr. Sangha built a network of retail and institutional investors across North America and Europe. Mr. Sangha left Global Securities in 2010 and joined Douglas Lake Minerals as head of Investor Relations/Corporate Development. While working at Douglas Lake Minerals, Mr. Sangha focused on financing, investor presentations, and corporate relations. Mr. Sangha currently holds this position with Verde Science.






  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
Current Price
Bid Ask Day's Range
VRCI News: Notification That Quarterly Report Will Be Submitted Late (nt 10-q) 08/17/2015 04:25:25 PM
VRCI News: Current Report Filing (8-k) 07/31/2015 05:00:41 PM
VRCI News: Verde Science Appoints International Banker Manfred A. Schauer 06/01/2015 08:00:00 AM
VRCI News: Current Report Filing (8-k) 05/27/2015 09:03:43 AM
VRCI News: Quarterly Report (10-q) 05/26/2015 03:54:17 PM
#8193   Nice chart! MakeaFuss 09/03/15 09:24:46 AM
#7617  Sticky Note VRCI SS ~ O/S 20,467,367 a/o Jan resx18 03/03/15 12:42:11 PM
#3350  Sticky Note excerpt/\one other thing, a national AM and online mick 06/02/14 06:58:47 PM
#8192 mick 09/02/15 07:38:45 PM
#8191   VRCI....has only 1 bid above a penny!! WOW....what MakeaFuss 08/25/15 03:13:16 PM
#8190 mick 08/25/15 12:40:03 PM
#8189   VRCI a nickel bid! Where'd all the pumpers MakeaFuss 08/24/15 12:32:09 PM
#8188 mick 08/16/15 06:31:13 PM
#8187   VRCI going to dollars!! What happened?? More like MakeaFuss 08/10/15 09:45:42 AM
#8186   So did I , won't be long now. $VRCI resx18 08/08/15 07:28:25 PM
#8185   Grabbed a bunch more $VRCI desandan 08/08/15 07:09:45 PM
#8184   Grabbed a bunch more $VRCI desandan 08/08/15 07:09:45 PM
#8183 mick 08/08/15 05:10:37 PM
#8182   They probably lost so much money here that Tony757 08/08/15 10:22:29 AM
#8181   Where'd all the VRCI cheerleaders go? MakeaFuss 08/08/15 07:51:33 AM
#8180   Famous last words! I can't wait till the MakeaFuss 08/01/15 01:51:06 PM
#8179   .30 by next week! $VRCI resx18 07/31/15 09:38:22 AM
#8178 Had to listen to this crap MakeaFuss 07/28/15 05:14:37 PM
#8177   This POS is back to the the Tony757 07/28/15 02:17:51 PM
#8176 mick 07/28/15 11:56:35 AM
#8175   3 CENTS BID! scam wiping out all who MakeaFuss 07/28/15 11:40:22 AM
#8174   I think we are getting close to some Tony757 07/28/15 09:23:50 AM
#8173   Strong Hands! $VRCI resx18 07/23/15 02:27:08 PM
#8172   Looks like someone is dumping all they can appleadam 07/23/15 12:10:31 PM
#8169   VRCI at .1999 is a great buy imo .. resx18 07/21/15 03:41:22 PM
#8168   Buying this stock anytime at any price will appleadam 07/21/15 03:36:40 PM
#8167   Loading at this PPS will prove to be resx18 07/21/15 01:31:00 AM
#8166   Huge volume today, awesome! So much interest in appleadam 07/20/15 06:45:21 PM
#8165   Resx you called this rebound easy money in dreubie 07/17/15 10:41:23 PM
#8164   .50 by Sept 1 .. mark it VRCI resx18 07/17/15 03:46:11 PM
#8163   Fifteen cents and no volume, no word from appleadam 07/17/15 12:06:12 PM
#8162   How does up 74% sound.. resx18 07/16/15 08:25:13 PM
#8161   Tough to load this puppy, but it's gonna TomKG 07/16/15 01:53:40 PM
#8160   How low is this POS going today ? Tony757 07/16/15 07:41:45 AM
#8159   I am loading tomorrow, this will be .20 resx18 07/16/15 12:18:56 AM
#8158   Rrsx18 this ticker has so much going for dreubie 07/15/15 11:37:02 PM
#8157   There is really no question about that druebie. resx18 07/15/15 11:34:12 PM
#8156   I wish I had the cash I'd buy dreubie 07/15/15 11:32:17 PM
#8155   Things are ready to heat up very soon resx18 07/15/15 11:23:19 PM
#8154   This will be over .50 in a couple resx18 07/15/15 11:19:16 PM
#8153   Totally agree. I dont have much money in sauce_boss 07/15/15 07:11:24 PM
#8152   What a POS we are back to where Tony757 07/15/15 04:49:38 PM
#8150   VRCI really has a lot going for them, dreubie 07/12/15 05:14:49 PM
#8149   VRCI is going nowhere, never has and never appleadam 07/10/15 04:07:01 PM
#8148   Making some headway, just a matter of time dreubie 07/10/15 12:48:19 PM
#8147 mick 07/10/15 10:45:30 AM
#8146   Yep, VRCI is pretty much dead. appleadam 07/07/15 08:06:12 PM
#8145   Our initial primary area of investigation is Cannabis-based resx18 07/07/15 05:37:54 PM
#8144   Nice to see $VRCI back on OTCQB ! resx18 07/07/15 05:29:45 PM
#8143   VRCI appears to be dead. appleadam 07/02/15 05:25:50 PM
#8142   We'll see some upward movement today imo dreubie 07/02/15 09:13:36 AM
#8141   .25 + tomorrow imo resx18 07/01/15 11:57:00 PM